Danaher Corporation (0R2B.L)
USD 195.33
(-2.03%)
USD 195.33
(-2.03%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.2 Billion USD | -41.74% |
| 2022 | 7.2 Billion USD | 12.06% |
| 2021 | 6.43 Billion USD | 76.44% |
| 2020 | 3.64 Billion USD | 42.58% |
| 2019 | 2.55 Billion USD | -3.53% |
| 2018 | 2.65 Billion USD | 6.37% |
| 2017 | 2.49 Billion USD | -2.41% |
| 2016 | 2.55 Billion USD | 46.2% |
| 2015 | 1.74 Billion USD | 6.59% |
| 2014 | 1.63 Billion USD | -36.74% |
| 2013 | 2.59 Billion USD | 12.67% |
| 2012 | 2.29 Billion USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 907 Million USD | -16.64% |
| 2024 Q1 | 1.08 Billion USD | 0.83% |
| 2024 Q3 | 818 Million USD | -9.81% |
| 2023 Q4 | 1.07 Billion USD | -4.43% |
| 2023 FY | 4.76 Billion USD | -33.92% |
| 2023 Q1 | 1.45 Billion USD | -35.04% |
| 2023 Q2 | 1.1 Billion USD | -23.72% |
| 2023 Q3 | 1.12 Billion USD | 2.08% |
| 2022 FY | 7.2 Billion USD | 12.06% |
| 2022 Q4 | 2.23 Billion USD | 41.98% |
| 2022 Q3 | 1.57 Billion USD | -6.43% |
| 2022 Q2 | 1.68 Billion USD | -2.61% |
| 2022 Q1 | 1.72 Billion USD | -3.52% |
| 2021 Q1 | 1.66 Billion USD | 38.42% |
| 2021 Q2 | 1.78 Billion USD | 7.47% |
| 2021 Q3 | 1.15 Billion USD | -35.13% |
| 2021 Q4 | 1.78 Billion USD | 54.4% |
| 2021 FY | 6.43 Billion USD | 76.44% |
| 2020 Q3 | 842 Million USD | -5.61% |
| 2020 Q4 | 1.2 Billion USD | 42.52% |
| 2020 FY | 3.64 Billion USD | 42.58% |
| 2020 Q1 | 576 Million USD | -25.52% |
| 2020 Q2 | 892 Million USD | 54.86% |
| 2019 FY | 2.55 Billion USD | -3.53% |
| 2019 Q4 | 773.4 Million USD | 26.56% |
| 2019 Q3 | 611.1 Million USD | -6.52% |
| 2019 Q2 | 653.7 Million USD | 100.64% |
| 2019 Q1 | 325.8 Million USD | -35.09% |
| 2018 FY | 2.65 Billion USD | 6.37% |
| 2018 Q2 | 673.8 Million USD | 18.92% |
| 2018 Q4 | 501.9 Million USD | -24.38% |
| 2018 Q3 | 663.7 Million USD | -1.5% |
| 2018 Q1 | 566.6 Million USD | -33.85% |
| 2017 Q2 | 557.3 Million USD | 15.19% |
| 2017 Q1 | 483.8 Million USD | -35.23% |
| 2017 FY | 2.49 Billion USD | -2.41% |
| 2017 Q4 | 856.6 Million USD | 49.73% |
| 2017 Q3 | 572.1 Million USD | 2.66% |
| 2016 Q2 | 418 Million USD | -28.64% |
| 2016 Q1 | 585.8 Million USD | 12.44% |
| 2016 Q3 | 402.6 Million USD | -3.68% |
| 2016 FY | 2.55 Billion USD | 46.2% |
| 2016 Q4 | 747 Million USD | 85.54% |
| 2015 FY | 1.74 Billion USD | 6.59% |
| 2015 Q4 | 521 Million USD | 37.14% |
| 2015 Q3 | 379.9 Million USD | 32.0% |
| 2015 Q2 | 287.8 Million USD | -48.42% |
| 2015 Q1 | 558 Million USD | -14.09% |
| 2014 FY | 1.63 Billion USD | -36.74% |
| 2014 Q4 | 649.5 Million USD | -4.67% |
| 2014 Q1 | 579.7 Million USD | -26.56% |
| 2014 Q3 | 681.3 Million USD | 7.7% |
| 2014 Q2 | 632.6 Million USD | 9.13% |
| 2013 Q3 | 597 Million USD | -3.21% |
| 2013 Q2 | 616.8 Million USD | -10.85% |
| 2013 FY | 2.59 Billion USD | 12.67% |
| 2013 Q1 | 691.9 Million USD | 9.76% |
| 2013 Q4 | 789.3 Million USD | 32.21% |
| 2012 Q4 | 630.4 Million USD | 0.0% |
| 2012 FY | 2.29 Billion USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 3168.269% |
| Accuray Incorporated | -15.54 Million USD | 27118.334% |
| Align Technology, Inc. | 445.05 Million USD | -843.708% |
| Elevance Health Inc. | 5.98 Billion USD | 29.848% |
| AxoGen, Inc. | -21.71 Million USD | 19440.578% |
| Boston Scientific Corporation | 1.59 Billion USD | -163.653% |
| CVS Health Corporation | 8.34 Billion USD | 49.664% |
| Cardinal Health, Inc. | 852 Million USD | -392.958% |
| Centene Corporation | 2.7 Billion USD | -55.44% |
| DaVita Inc. | 691.53 Million USD | -507.345% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 19.878% |
| Hologic, Inc. | 789.5 Million USD | -431.982% |
| Humana Inc. | 2.48 Billion USD | -68.742% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -397.017% |
| Laboratory Corporation of America Holdings | 418 Million USD | -904.785% |
| Masimo Corporation | 81.5 Million USD | -5053.374% |
| McKesson Corporation | 3 Billion USD | -39.907% |
| Patterson Companies, Inc. | 185.93 Million USD | -2158.902% |
| Quest Diagnostics Incorporated | 854 Million USD | -391.803% |
| ResMed Inc. | 1.02 Billion USD | -311.381% |
| Henry Schein, Inc. | 416 Million USD | -909.615% |
| Teladoc Health, Inc. | -220.36 Million USD | 2005.903% |
| Universal Health Services, Inc. | 717.79 Million USD | -485.125% |
| Veeva Systems Inc. | 525.7 Million USD | -698.927% |
| Baxter International Inc. | 2.65 Billion USD | -58.133% |
| Becton, Dickinson and Company | 1.48 Billion USD | -183.019% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | -133.593% |
| Stryker Corporation | 3.16 Billion USD | -32.701% |
| Medtronic plc | 3.67 Billion USD | -14.255% |